| 1 | 9286755 | Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo. | J Bone Miner Res | 1997 Sep |
2 |
| 2 | 10430032 | Localization of rat cathepsin K in osteoclasts and resorption pits: inhibition of bone resorption and cathepsin K-activity by peptidyl vinyl sulfones. | Biol Chem | 1999 Jun |
7 |
| 3 | 10673380 | Structure-based development of pyridoxal propionate derivatives as specific inhibitors of cathepsin K in vitro and in vivo. | Biochem Biophys Res Commun | 2000 Jan 27 |
3 |
| 4 | 10967538 | Bisphosphonate administration alters subcellular localization of vacuolar-type H(+)-ATPase and cathepsin K in osteoclasts during experimental movement of rat molars. | Anat Rec | 2000 Sep 1 |
4 |
| 5 | 11311061 | Azepanone-based inhibitors of human and rat cathepsin K. | J Med Chem | 2001 Apr 26 |
1 |
| 6 | 11938609 | A cysteine protease inhibitor prevents suspension-induced declines in bone weight and strength in rats. | J Physiol Anthropol Appl Human Sci | 2002 Jan |
1 |
| 7 | 11996914 | A potent small molecule, nonpeptide inhibitor of cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized rat. | Bone | 2002 May |
2 |
| 8 | 12650749 | Complementary use of ion trap/time-of-flight mass spectrometry in combination with capillary high-pressure liquid chromatography: early characterization of in vivo metabolites of the cathepsin K inhibitor NVP-AAV490 in rat. | J Chromatogr B Analyt Technol Biomed Life Sci | 2003 Apr 25 |
2 |
| 9 | 14527964 | Blockade of the sympathetic nervous system degrades ligament in a rat MCL model. | J Appl Physiol (1985) | 2004 Feb |
2 |
| 10 | 14736240 | Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k. | J Med Chem | 2004 Jan 29 |
3 |
| 11 | 15542040 | Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts. | Bone | 2004 Nov |
2 |
| 12 | 15896958 | Acyclic cyanamide-based inhibitors of cathepsin K. | Bioorg Med Chem Lett | 2005 Jun 15 |
6 |
| 13 | 15929988 | Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts. | J Biol Chem | 2005 Aug 5 |
5 |
| 14 | 15982880 | P2-P3 conformationally constrained ketoamide-based inhibitors of cathepsin K. | Bioorg Med Chem Lett | 2005 Aug 1 |
3 |
| 15 | 16290936 | Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors? | Bioorg Med Chem Lett | 2006 Feb 15 |
6 |
| 16 | 16302794 | Design and synthesis of tri-ring P3 benzamide-containing aminonitriles as potent, selective, orally effective inhibitors of cathepsin K. | J Med Chem | 2005 Dec 1 |
1 |
| 17 | 16302795 | Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity. | J Med Chem | 2005 Dec 1 |
3 |
| 18 | 16509577 | Structure activity relationships of 5-, 6-, and 7-methyl-substituted azepan-3-one cathepsin K inhibitors. | J Med Chem | 2006 Mar 9 |
2 |
| 19 | 16622732 | High-turnover osteoporosis is induced by cyclosporin A in rats. | J Bone Miner Metab | 2006 |
1 |
| 20 | 16699068 | An orally active cathepsin K inhibitor, furan-2-carboxylic acid, 1-{1-[4-fluoro-2-(2-oxo-pyrrolidin-1-yl)-phenyl]-3-oxo-piperidin-4-ylcarbamoyl}-cyclohexyl)-amide (OST-4077), inhibits osteoclast activity in vitro and bone loss in ovariectomized rats. | J Pharmacol Exp Ther | 2006 Aug |
3 |
| 21 | 17916452 | Increased cathepsin K and tartrate-resistant acid phosphatase expression in bone of streptozotocin-induced diabetic rats. | Bone | 2007 Dec |
1 |
| 22 | 18572405 | Discovery of selective and nonpeptidic cathepsin S inhibitors. | Bioorg Med Chem Lett | 2008 Jul 15 |
1 |
| 23 | 18664521 | Species differences between human and rat in the substrate specificity of cathepsin K. | J Biochem | 2008 Oct |
1 |
| 24 | 18707091 | Effect of cathepsin K inhibitors on bone resorption. | J Med Chem | 2008 Sep 11 |
2 |
| 25 | 18758923 | Feasibility of using a bone-targeted, macromolecular delivery system coupled with prostaglandin E(1) to promote bone formation in aged, estrogen-deficient rats. | Pharm Res | 2008 Dec |
3 |
| 26 | 19699734 | Curcumin suppresses increased bone resorption by inhibiting osteoclastogenesis in rats with streptozotocin-induced diabetes. | Eur J Pharmacol | 2009 Oct 25 |
1 |
| 27 | 20149657 | Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin K inhibitors. | Bioorg Med Chem Lett | 2010 Mar 1 |
2 |
| 28 | 21806983 | Administration of zinc inhibits osteoclastogenesis through the suppression of RANK expression in bone. | Eur J Pharmacol | 2011 Oct 1 |
1 |
| 29 | 21950592 | Low dose of propranolol down-modulates bone resorption by inhibiting inflammation and osteoclast differentiation. | Br J Pharmacol | 2012 Apr |
1 |
| 30 | 22576626 | Ethanol increases osteoclastogenesis associated with the increased expression of RANK, PU.1 and MITF in vitro and in vivo. | Int J Mol Med | 2012 Jul |
1 |
| 31 | 23243450 | Effects and interaction of icariin, curculigoside, and berberine in er-xian decoction, a traditional chinese medicinal formula, on osteoclastic bone resorption. | Evid Based Complement Alternat Med | 2012 |
1 |
| 32 | 23529168 | Cathepsin K knockout alleviates pressure overload-induced cardiac hypertrophy. | Hypertension | 2013 Jun |
1 |
| 33 | 23543761 | Cathepsin K is involved in development of psoriasis-like skin lesions through TLR-dependent Th17 activation. | J Immunol | 2013 May 1 |
2 |
| 34 | 23735664 | Zinc supplementation inhibits the increase in osteoclastogenesis and decrease in osteoblastogenesis in streptozotocin-induced diabetic rats. | Eur J Pharmacol | 2013 Aug 15 |
1 |
| 35 | 24317478 | ONO-5334, a cathepsin K inhibitor, improves bone strength by preferentially increasing cortical bone mass in ovariectomized rats. | J Bone Miner Metab | 2014 Nov |
1 |
| 36 | 24743169 | Remodeling of aorta extracellular matrix as a result of transient high oxygen exposure in newborn rats: implication for arterial rigidity and hypertension risk. | PLoS One | 2014 |
1 |
| 37 | 24819928 | Azilsartan increases levels of IL-10, down-regulates MMP-2, MMP-9, RANKL/RANK, Cathepsin K and up-regulates OPG in an experimental periodontitis model. | PLoS One | 2014 |
2 |
| 38 | 24879020 | Galnon, a galanin receptor agonist, improves intrinsic cortical bone tissue properties but exacerbates bone loss in an ovariectomised rat model. | J Musculoskelet Neuronal Interact | 2014 Jun |
1 |
| 39 | 25036175 | Drynaria total flavonoids decrease cathepsin K expression in ovariectomized rats. | Genet Mol Res | 2014 Jun 9 |
4 |
| 40 | 25557511 | Lemnalol attenuates mast cell activation and osteoclast activity in a gouty arthritis model. | J Pharm Pharmacol | 2015 Feb |
1 |
| 41 | 25636877 | Antiosteoporotic activity and constituents of Podocarpium podocarpum. | Phytomedicine | 2015 Jan 15 |
1 |
| 42 | 25990199 | Cathepsin K Inhibitor Regulates Inflammation and Bone Destruction in Experimentally Induced Rat Periapical Lesions. | J Endod | 2015 Sep |
1 |
| 43 | 26694734 | Effects of combined ovariectomy with dexamethasone on rat lumbar vertebrae. | Menopause | 2016 Apr |
4 |
| 44 | 27154501 | Diversity of multinucleated giant cells by microstructures of hydroxyapatite and plasma components in extraskeletal implantation model. | Acta Biomater | 2016 Jul 15 |
1 |
| 45 | 27245552 | The novel bisphosphonate disodium dihydrogen-4-[(methylthio) phenylthio] methanebisphosphonate increases bone mass in post-ovariectomy rats. | J Pharmacol Sci | 2016 May |
1 |
| 46 | 27578589 | [Role of epithelial sodium channel in rat osteoclast differentiation and bone resorption]. | Nan Fang Yi Ke Da Xue Xue Bao | 2016 Aug 20 |
1 |
| 47 | 27981392 | Histological evidence that metformin reverses the adverse effects of diabetes on orthodontic tooth movement in rats. | J Mol Histol | 2017 Apr |
1 |
| 48 | 28465233 | Aesculin modulates bone metabolism by suppressing receptor activator of NF-κB ligand (RANKL)-induced osteoclastogenesis and transduction signals. | Biochem Biophys Res Commun | 2017 Jun 17 |
1 |
| 49 | 28703398 | Tissue dynamics and regenerative outcome in two resorbable non-cross-linked collagen membranes for guided bone regeneration: A preclinical molecular and histological study in vivo. | Clin Oral Implants Res | 2018 Jan |
2 |
| 50 | 28878388 | Promotion effect of extracts from plastrum testudinis on alendronate against glucocorticoid-induced osteoporosis in rat spine. | Sci Rep | 2017 Sep 6 |
2 |